CSL -2.1% at $345.39 drags healthcare to worst sector — August earnings the re-rating catalyst
CSL Ltd's $7.37 fall to $345.39 was the session's standout single-stock move, pulling healthcare down 2.09% and making it the worst sector by more than double the next worst (banks -1.07%). No company-specific announcement triggered the move — this reads as late-cycle profit-taking or position-trimming ahead of CSL's August interim results. CSL is a core holding in most super funds' Australian equity allocation; any sustained weakness from $340 support risks triggering further super fund re-weighting away from healthcare.
Read at Small Caps ↗